In the last trading session, 1.18 million Aspen Aerogels Inc (NYSE:ASPN) shares changed hands as the company’s beta touched 2.29. With the company’s per share price at $7.38 changed hands at $0.45 or 6.49% during last session, the market valuation stood at $605.60M. ASPN’s last price was a discount, traded about -349.19% off its 52-week high of $33.15. The share price had its 52-week low at $6.70, which suggests the last value was 9.21% up since then. When we look at Aspen Aerogels Inc’s average trading volume, we note the 10-day average is 1.63 million shares, with the 3-month average coming to 2.00 million.
Analysts gave the Aspen Aerogels Inc (ASPN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.33. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ASPN as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. Aspen Aerogels Inc’s EPS for the current quarter is expected to be -0.03.
Aspen Aerogels Inc (NYSE:ASPN) trade information
Instantly ASPN was in green as seen at the end of in last trading. With action -7.17%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -37.88%, with the 5-day performance at -7.17% in the red. However, in the 30-day time frame, Aspen Aerogels Inc (NYSE:ASPN) is -37.19% down. Looking at the short shares, we see there were 9.72 million shares sold at short interest cover period of 3.77 days.
The consensus price target for the stock as assigned by Wall Street analysts is 33, meaning bulls need an upside of 77.64% from its current market value. According to analyst projections, ASPN’s forecast low is 33 with 33 as the target high. To hit the forecast high, the stock’s price needs a -347.15% plunge from its current level, while the stock would need to soar -347.15% for it to hit the projected low.
Aspen Aerogels Inc (ASPN) estimates and forecasts
Year-over-year growth is forecast to reach -13.36% down from the last financial year.
Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 82.75M. 7 analysts are of the opinion that Aspen Aerogels Inc’s revenue for the current quarter will be 90.87M. The company’s revenue for the corresponding quarters a year ago was 94.5M and 117.77M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -12.44%. The estimates for the next quarter sales put growth at -22.84%.
The 2025 estimates are for Aspen Aerogels Inc earnings to decrease by -16.99%, but the outlook for the next 5-year period is at 81.51% per year.
ASPN Dividends
Aspen Aerogels Inc is expected to release its next quarterly earnings report on 2025-Feb-11.
Aspen Aerogels Inc (NYSE:ASPN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.87% of Aspen Aerogels Inc shares while 92.94% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 94.71%. There are 92.94% institutions holding the Aspen Aerogels Inc stock share, with KIM, LLC the top institutional holder. As of 2024-06-30, the company held 16.0872% of the shares, roughly 12.28 million ASPN shares worth $292.89 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 5.9295% or 4.49 million shares worth $107.14 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . With 2.57 shares estimated at $19.0 million under it, the former controlled 3.14% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.02% of the shares, roughly 1.65 shares worth around $12.21 million.
